Related Experiment Video
Updated: Apr 26, 2026
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
[Lunasin--a novel chemopreventive peptide]
Abstract:
Lunasin is a bioactive peptide originally isolated from soybean and has demonstrated chemopreventive and anticancer properties against: skin, colon, prostate and breast cancers. Lunasin by binding to the receptors of colon cancer cells prevents its adhesion to the liver tissue. When the receptor is blocked, new blood vessels cannot differentiate which prevent the spread of cancer. In the model estrogen-independent breast cancer, lunasin and aspirin administration inhibits cell proliferation, arrest cell cycle in S-phase as well as a decreases expression of cancer genes. Lunasin has also been found to exert potent antioxidant properties, reducing lipopolysaccharide induced production of ROS by macrophage cells, and acting as a potent free radical scavenger. Using the modifying the of DNA method it has been demonstrated that CpG islands were hypomethylated in RWPE-1 cell lines and hypermethylated RWPE-2 in cell line.Despite of numerous and promising evidence of antitumor activity of lunasin, there are still not explained all the mechanisms of its action in the processes of carcinogenesis.
Insights
Lunasin, a soybean peptide, shows anticancer effects by inhibiting cancer cell spread and proliferation. Further research is needed to fully understand its mechanisms in carcinogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Context:
- Lunasin, a bioactive peptide from soybeans, exhibits significant chemopreventive and anticancer properties.
- Its mechanisms are being investigated across various cancer types, including skin, colon, prostate, and breast cancer.
Purpose:
- To summarize the known anticancer activities and mechanisms of lunasin.
- To highlight its potential in cancer chemoprevention and therapy.
Summary:
- Lunasin prevents colon cancer cell adhesion to the liver by blocking specific receptors, thereby inhibiting metastasis.
- In estrogen-independent breast cancer models, lunasin inhibits cell proliferation, induces S-phase arrest, and downregulates cancer gene expression.
- It possesses potent antioxidant properties, scavenging reactive oxygen species (ROS) and reducing their production by macrophages.
- Lunasin influences DNA methylation, causing hypomethylation of CpG islands in RWPE-1 cells and hypermethylation in RWPE-2 cells.
Impact:
- Lunasin demonstrates broad-spectrum anticancer potential, offering therapeutic avenues for multiple cancer types.
- Its antioxidant and anti-metastatic properties contribute to its chemopreventive efficacy.
- Understanding lunasin's detailed mechanisms, including its effects on DNA methylation, can lead to novel cancer treatment strategies.
